Pluristem Therapeutics, Inc. (PSTI) was a big mover last session, as the company saw its shares nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the volatile price range of $3.19–$3.37 in the past one-month time frame.
This biotechnology stock witnessed no estimate revisions over the past 30 days. The Zacks Consensus Estimate also remained unchanged during the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Pluristem has a Zacks Rank #2 (Buy), while its Earnings ESP is 0.00%
Other players in the industry, which look attractive at current levels, include Coronado Biosciences, Inc. (CNDO), Gentium S.p.A (GENT) and Heska Corporation (HSKA). All these stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
PLURISTEM THERAPEUTICS INC (PSTI): Free Stock Analysis Report
CORONADO BIOSCIENCES INC (CNDO): Free Stock Analysis Report
GENTIUM SPA GENTIUM SPA ADS ADSS (GENT): Free Stock Analysis Report
HESKA CORP (HSKA): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Personal Investing Ideas & Strategies